STORM Therapeutics (STORM), a Cambridge-based BioTech company tarreceiveing RNA modifications to reprogram cells and develop novel cancer therapies, today announced…
Read More

STORM Therapeutics (STORM), a Cambridge-based BioTech company tarreceiveing RNA modifications to reprogram cells and develop novel cancer therapies, today announced…
Read More
Myotonic Dystrophy Treatment Market “The global myotonic dystrophy treatment market reached US$874.39 million in 2023 and is expected to reach…
Read More